Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy Melanson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pain Physician|February 23, 2017
Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic PainMarion L Snyder, Corrine R Fantz, Stacy Melanson
Pain Physician|July 24, 2014
KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic painAlicia Darragh, Marion L Snyder, Adam S Ptolemy, et al.
The Primary Care Companion for CNS Disorders|April 18, 2025
Is My Patient Diverting Their Lorazepam?Sacha Uljon, M Lauren Donnelly-Morell, Nicole Tolan, et al.
The Journal of Applied Laboratory Medicine|February 26, 2026
Abstracts from the 2025 ADLM Preanalytical Phase Conference-Advancing Preanalytics: From Innovative Breakthroughs to Practical ApplicationsDarci R Block, Raffick A R Bowen, Stacy Melanson, et al.
Pain Physician|December 5, 2018
Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain ManagementRalitsa Gencheva, Athena Petrides, Michalis Kantartjis, et al.
Clinical Chemistry|March 26, 2024
Challenges Associated with the Effective Implementation of New Laboratory Tests-The International ExperienceAndrew St John, Christopher P Price, Rogier Hopstaken, et al.
Microbiology Spectrum|March 21, 2022
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine RecipientsNicole V Tolan, Amy C Sherman, Guohai Zhou, et al.
Transfusion|December 15, 2018
Electronic patient identification for sample labeling reduces wrong blood in tube errorsRichard M Kaufman, Anh Dinh, Claudia S Cohn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pain Physician|February 23, 2017
Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic PainMarion L Snyder, Corrine R Fantz, Stacy Melanson
Pain Physician|July 24, 2014
KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic painAlicia Darragh, Marion L Snyder, Adam S Ptolemy, et al.
The Primary Care Companion for CNS Disorders|April 18, 2025
Is My Patient Diverting Their Lorazepam?Sacha Uljon, M Lauren Donnelly-Morell, Nicole Tolan, et al.
The Journal of Applied Laboratory Medicine|February 26, 2026
Abstracts from the 2025 ADLM Preanalytical Phase Conference-Advancing Preanalytics: From Innovative Breakthroughs to Practical ApplicationsDarci R Block, Raffick A R Bowen, Stacy Melanson, et al.
Pain Physician|December 5, 2018
Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain ManagementRalitsa Gencheva, Athena Petrides, Michalis Kantartjis, et al.
Clinical Chemistry|March 26, 2024
Challenges Associated with the Effective Implementation of New Laboratory Tests-The International ExperienceAndrew St John, Christopher P Price, Rogier Hopstaken, et al.
Microbiology Spectrum|March 21, 2022
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine RecipientsNicole V Tolan, Amy C Sherman, Guohai Zhou, et al.
Transfusion|December 15, 2018
Electronic patient identification for sample labeling reduces wrong blood in tube errorsRichard M Kaufman, Anh Dinh, Claudia S Cohn, et al.
Pageof 1